Diagnamed Hldgs (OTC:DGNMF) Stock, Quote.Headers.trade-ideas

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

DIAGNAMED HLDGS CORP by Diagnamed Holdings Corp.

Diagnamed Holdings Corp

Press Releases

DiagnaMed Advances Hydrogen Energy Technology Innovation

DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC

DiagnaMed Announces LIFE Offering of up to $510,000

News

Health Care

Contracts

Revive Therapeutics Announces LOI to Acquire DiagnaMed's Molecular Hydrogen Program

DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program

DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District

General

DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology

Management

DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario

DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben

Comments

Diagnamed Hldgs

Diagnamed Hldgs (OTC:DGNMF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell